Crane Co. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Crane Co. on April 29, 2019. The filing reports on the Company's results of operations for the quarter ended March 31, 2019, and details events occurring at the Annual Meeting of Shareholders held on the same date. The filing also provides an extensive update on asbestos liability claims and costs.
Key Financial Metrics and Asbestos Liability
The filing does not provide specific revenue, profit, or cash flow figures for the quarter; these are referenced in the attached press release (Exhibit 99.1). However, the filing details significant asbestos-related financial data:
- Asbestos Costs Incurred (Q1 2019): Total gross settlement and defense costs incurred were $26.5 million ($21.4 million settlement/indemnity and $5.1 million defense).
- Asbestos Cash Payments (Q1 2019): Total pre-tax cash payments, net of insurance receipts, were $9.7 million.
- Asbestos Liability Reserve: The recorded liability for pending and future claims through 2059 was $504 million as of March 31, 2019 (down from $696 million as of December 31, 2016).
- Insurance Receivable: The asset recorded for probable insurance reimbursements was $88 million as of March 31, 2019.
- Pending Claims: There were 28,498 pending asbestos claims as of March 31, 2019.
Material Changes and Corporate Governance
Board of Directors: Mr. Philip Lochner retired from the Board of Directors as of the Annual Meeting on April 29, 2019. Ten directors were elected to serve until the 2020 Annual Meeting.
Shareholder Votes: Stockholders approved the ratification of Deloitte & Touche LLP as independent auditors and approved, on an advisory basis, the compensation of named executive officers.
Asbestos Activity: Compared to the prior year quarter, settlement and indemnity costs incurred increased from $8.3 million to $21.4 million. Total costs incurred rose from $14.8 million in Q1 2018 to $26.5 million in Q1 2019.
Outlook, Risks, and Contingencies
Asbestos Liability Estimate: Management determined that no change in the asbestos liability estimate was warranted for the period ended March 31, 2019. The estimate covers claims projected through 2059. The Company notes that actual experience with mesothelioma claims generally approximated assumptions.
Risks and Uncertainties: The filing highlights significant uncertainties regarding the ultimate exposure for asbestos claims. Factors affecting the liability estimate include the number of new mesothelioma claims, average settlement costs, dismissal rates, and defense costs. Legislative changes, case law trends, and the financial viability of insurers could materially alter the estimated liability and insurance recoveries.
Insurance Coverage: The Company has "coverage-in-place" agreements with eleven excess insurer groups and has settled obligations with ten other groups for an aggregate of $82.5 million. Approximately 21% of the liability is forecasted to be reimbursed by insurers.
Investor Verification Checklist
- Review Exhibit 99.1 (Earnings Press Release) for specific Q1 2019 revenue, net income, and earnings per share figures not detailed in this 8-K text.
- Verify the $504 million asbestos liability reserve and the $88 million insurance receivable on the balance sheet.
- Monitor the trend of new mesothelioma claims, which drive approximately 90% of aggregate settlement and defense costs.
- Assess the impact of the $26.5 million in incurred asbestos costs on the Company's operating margins for the quarter.
- Confirm the status of the single remaining solvent excess insurer that has not entered into a final settlement agreement.